BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND ELK4, SAP1, 2005, ENSG00000158711, P28324 AND Treatment
562 results:

  • 1. Recent trends in cervical cancer incidence, stage at diagnosis, and mortality according to county-level income in the United States, 2000-2019.
    Amboree TL; Damgacioglu H; Sonawane K; Adsul P; Montealegre JR; Deshmukh AA
    Int J Cancer; 2024 May; 154(9):1549-1555. PubMed ID: 38270521
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. EXOSC5 maintains cancer stem cell activity in endometrial cancer by regulating the NTN4/integrin β1 signalling axis.
    Huang YH; Wang WL; Wang PH; Lee HT; Chang WW
    Int J Biol Sci; 2024; 20(1):265-279. PubMed ID: 38164180
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The Cervical cancer treatment Gap in Mexico Under
    McClellan SP; Unger-Saldaña K; Espinosa-Tamez P; Suazo-Zepeda E; Potter MB; Barquet-Muñoz SA; Torres-Ibarra L; Lamadrid-Figueroa H; Lajous M
    Health Syst Reform; 2023 Dec; 9(1):2272371. PubMed ID: 37944505
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Impact of multimorbidity and polypharmacy on mortality after cancer: a nationwide registry-based cohort study in Denmark 2005-2017.
    Thomsen MK; Løppenthin KB; Bidstrup PE; Andersen EW; Dalton S; Petersen LN; Pappot H; Mortensen CE; Christensen MB; Frølich A; Lassen U; Johansen C
    Acta Oncol; 2023 Dec; 62(12):1653-1660. PubMed ID: 37874076
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. treatment outcomes of early-stage endometrial cancer patients: A propensity score matching of vaginal brachytherapy versus pelvic radiotherapy.
    Petsuksiri J; Setakornnukul J; Berpan A; Thephamongkhol K; Dankulchai P; Jaishuen A
    J Obstet Gynaecol Res; 2023 Dec; 49(12):2918-2928. PubMed ID: 37786395
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinical features and demographic characteristics of gestational trophoblastic neoplasia: Single center experience and the SEER database.
    Hou YM; Li PP; Yu H; Feng F; He XY; Chen BH; Li JL; Yao HY; An RF
    Biomol Biomed; 2024 Jan; 24(1):176-187. PubMed ID: 37485958
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Multi-institutional analysis of cervical esophageal carcinoma patients treated with definitive chemoradiotherapy: TROD 01-005 study.
    Guler OC; Oymak E; Yazici G; Akagunduz OO; Cetinayak O; Erpolat P; Aksoy A; Duzova M; Yildirim BA; Kurt M; Canyilmaz E; Yavas G; Akyurek S; Oksuz DC; Saglam EK; Celik OK; Ozyar E; Cengiz M; Onal C
    Oncol Res; 2023; 31(3):299-306. PubMed ID: 37305394
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Recurrent High-Grade Squamous Intraepithelial Lesion After Loop Excision Procedure Versus Loop Procedure With Top Hat.
    Francoeur AA; Furey KB; Ramirez J; Klomhaus AM; Holschneider C; Garcia LM
    J Low Genit Tract Dis; 2023 Jul; 27(3):193-197. PubMed ID: 37285236
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Decision-making for Subsequent Therapy for Patients With Recurrent or Advanced Endometrial cancer Based on the Platinum-free Interval.
    Yasunaga M; Yahata H; Okugawa K; Hori E; Hachisuga K; Maenohara S; Kodama K; Yagi H; Ohgami T; Onoyama I; Asanoma K; Kato K
    Am J Clin Oncol; 2023 Sep; 46(9):387-391. PubMed ID: 37272748
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Fertility-sparing hormonal treatment in patients with stage I endometrial cancer of grade 2 without myometrial invasion and grade 1-2 with superficial myometrial invasion: Gynecologic Oncology Research Investigators coLLaborAtion study (GORILLA-2001).
    Lee AJ; Yang EJ; Kim NK; Kim Y; Suh DH; Kim J; Son JH; Kong TW; Chang SJ; Hwang DW; Park SJ; Kim HS; Yoo JG; Lee SJ; Lee YY; Shim SH
    Gynecol Oncol; 2023 Jul; 174():106-113. PubMed ID: 37172410
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Increased incidence and improved survival in endometrial cancer in Sweden 1960-2014: a population-based registry survey.
    Herbst F; Dickman PW; Moberg L; Högberg T; Borgfeldt C
    BMC Cancer; 2023 Mar; 23(1):276. PubMed ID: 36973669
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A federated approach to identify women with early-stage cervical cancer at low risk of lymph node metastases.
    Wenzel HHB; Hardie AN; Moncada-Torres A; Høgdall CK; Bekkers RLM; Falconer H; Jensen PT; Nijman HW; van der Aa MA; Martin F; van Gestel AJ; Lemmens VEPP; Dahm-Kähler P; Alfonzo E; Persson J; Ekdahl L; Salehi S; Frøding LP; Markauskas A; Fuglsang K; Schnack TH
    Eur J Cancer; 2023 May; 185():61-68. PubMed ID: 36965329
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Outcomes associated with treatment to all sites of disease in patients with stage IVB cancer of the cervix.
    Peleg Hasson S; Felder S; Helpman L; Taylor A; Shalamov M; Abuakar S; Bauer S; Shapira-Frommer R; Greenhouse I; Korach J; Rabin T; Goldstein J; Saad A
    Int J Gynecol Cancer; 2023 May; 33(5):683-691. PubMed ID: 36963801
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. An update of oncologic and obstetric outcomes after abdominal trachelectomy using the FIGO 2018 staging system for cervical cancer: a single-institution retrospective analysis.
    Okugawa K; Yahata H; Ohgami T; Yasunaga M; Asanoma K; Kobayashi H; Kato K
    J Gynecol Oncol; 2023 May; 34(3):e41. PubMed ID: 36807744
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Influencing factors and risk prediction model for cervical cancer recurrence.
    Li J; Luo J; Liu G; Yan S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 47(12):1711-1720. PubMed ID: 36748382
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. More than cervical cancer: Understanding racial/ethnic disparities in oropharyngeal cancer outcomes among males by HPV status.
    Villalona S; Ferrante J; Villalona S; Stroup A
    Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36696662
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A retrospective study of immunotherapy using the cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin (BCG-CWS) for cervical cancer.
    Shibata T; Takata E; Sakamoto J; Shioya A; Yamada S; Takakura M; Sasagawa T
    Medicine (Baltimore); 2022 Dec; 101(52):e32481. PubMed ID: 36595982
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical cancer Elimination Initiative.
    Singh D; Vignat J; Lorenzoni V; Eslahi M; Ginsburg O; Lauby-Secretan B; Arbyn M; Basu P; Bray F; Vaccarella S
    Lancet Glob Health; 2023 Feb; 11(2):e197-e206. PubMed ID: 36528031
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. MED12 mutations in uterine leiomyomas: prediction of volume reduction by gonadotropin-releasing hormone agonists.
    Nagai K; Asano R; Sekiguchi F; Asai-Sato M; Miyagi Y; Miyagi E
    Am J Obstet Gynecol; 2023 Feb; 228(2):207.e1-207.e9. PubMed ID: 36150519
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Comparison of cancer Survival Trends in Hungary in the Periods 2001-2005 and 2011-2015 According to a Population-Based cancer Registry.
    Kenessey I; Szőke G; Dobozi M; Szatmári I; Wéber A; Fogarassy G; Nagy P; Kásler M; Polgár C; Vathy-Fogarassy Á
    Pathol Oncol Res; 2022; 28():1610668. PubMed ID: 36147657
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 29.